Published in Virology on April 01, 1987
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Protective immune response against foot-and-mouth disease. J Virol (1992) 1.77
Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol (1989) 1.59
Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 1.20
Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiol Infect (1993) 1.02
Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology (2002) 0.93
Epitopes functional in neutralization of varicella-zoster virus. J Clin Microbiol (1990) 0.87
An overview on ELISA techniques for FMD. Virol J (2011) 0.80
Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis. PLoS One (2016) 0.75
A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol (1975) 2.62
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Recombination in RNA. Cell (1982) 2.14
The structure and antigenicity of a type C foot-and-mouth disease virus. Structure (1994) 1.82
Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther (2013) 1.82
Protective immune response against foot-and-mouth disease. J Virol (1992) 1.77
Self management of oral anticoagulation: randomised trial. BMJ (2005) 1.69
HIV infection and AIDS in China, 1985 through 1994. Am J Public Health (1996) 1.64
An investigation of some factors affecting cross-reactivation between influenza A viruses. J Gen Virol (1971) 1.59
A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57
Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol (1987) 1.53
Natural CD8+CD122+ T cells are more potent in suppression of allograft rejection than CD4+CD25+ regulatory T cells. Am J Transplant (2013) 1.52
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol (2001) 1.52
A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med (1997) 1.52
Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology (2001) 1.49
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods (1986) 1.48
Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies. Acta Cytol (2005) 1.48
Enzyme-labelled immunosorbent assay techniques in foot-and-mouth disease virus research. J Hyg (Lond) (1978) 1.45
IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol (1996) 1.45
The maize retinoblastoma protein homologue ZmRb-1 is regulated during leaf development and displays conserved interactions with G1/S regulators and plant cyclin D (CycD) proteins. Plant Mol Biol (1998) 1.42
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature (1981) 1.39
A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiol Infect (1990) 1.36
Characterization of Vilyuisk virus as a picornavirus. J Med Virol (1983) 1.35
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C. Hepatology (2011) 1.35
Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine (2006) 1.35
Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.34
Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J Virol (1998) 1.28
Molecular analysis of encephalomyocarditis viruses isolated from pigs and rodents in Italy. Virus Res (1998) 1.27
The cloning of plant E2F, a retinoblastoma-binding protein, reveals unique and conserved features with animal G(1)/S regulators. Nucleic Acids Res (1999) 1.27
An extended genetic recombination map for foot-and-mouth diseases virus. J Gen Virol (1977) 1.27
Experimental demonstration of isotropic negative permeability in a three-dimensional dielectric composite. Phys Rev Lett (2008) 1.27
The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27
Multiple sites of recombination within the RNA genome of foot-and-mouth disease virus. Virus Res (1985) 1.26
Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol (1993) 1.25
A further step in the evolution of rabbit hemorrhagic disease virus: the appearance of the first consistent antigenic variant. Virus Res (1998) 1.25
Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology (1986) 1.24
Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2003) 1.23
Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol (1982) 1.23
European brown hare syndrome virus: relationship to rabbit hemorrhagic disease virus and other caliciviruses. J Virol (1994) 1.23
Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. Virus Res (1995) 1.23
A serogroup specific enzyme-linked immunosorbent assay for the detection and identification of African horse sickness viruses. J Virol Methods (1991) 1.23
The structural and functional analysis of the hemoglobin D component from chicken. J Biol Chem (1999) 1.22
Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 1.20
Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol (1996) 1.17
The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol (1986) 1.16
Partial characterization of an 89-kDa highly immunoreactive protein from Chlamydia psittaci A/22 causing ovine abortion. FEMS Microbiol Lett (1991) 1.16
Identification of unacceptable background caused by non-specific protein adsorption to the plastic surface of 96-well immunoassay plates using a standardized enzyme-linked immunosorbent assay procedure. J Immunol Methods (1999) 1.13
Immunopathogenesis of classical swine fever: role of monocytic cells. Immunology (1999) 1.13
Guanidine inhibition of poliovirus: a dependence of viral RNA synthesis on the configuration of structural protein. Virology (1970) 1.12
Value of endoscopic ultrasonography in the management of portal hypertension. Endoscopy (1992) 1.12
A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods (1985) 1.11
Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. Cell Immunol (1999) 1.10
Volatile anesthetics for periprocedural cardiac protection. A review. Minerva Cardioangiol (2008) 1.10
Expression and localization of Na(+)-HCO(3)(-) cotransporter in bovine corneal endothelium. Am J Physiol Cell Physiol (2000) 1.10
An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity. SAR QSAR Environ Res (2002) 1.10
Endoscopic ultrasonography in the diagnosis of gastric submucosal tumor. Gastrointest Endosc (1989) 1.10
Monoclonal antibodies: implications for virology. Brief review. Arch Virol (1986) 1.10
High IFN-alpha responses associated with depletion of lymphocytes and natural IFN-producing cells during classical swine fever. J Interferon Cytokine Res (2006) 1.09
The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus. Virology (2010) 1.07
Small-intestinal bleeding due to metastatic renal cell cancer. Endoscopy (2011) 1.07
Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus strains using monoclonal antibodies. Biologicals (1991) 1.06
Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies. Biochim Biophys Acta (1986) 1.06
Traditional phytotherapy in the Roccamonfina volcanic group, Campania, southern Italy. J Ethnopharmacol (1988) 1.06
Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. J Gen Virol (1989) 1.06
Porcine bone marrow myeloid cells: phenotype and adhesion molecule expression. J Leukoc Biol (1997) 1.04
Dendritic cells harbor infectious porcine circovirus type 2 in the absence of apparent cell modulation or replication of the virus. J Virol (2003) 1.04
Temperature-sensitive mutants of foot-and-mouth disease virus with altered structural polypeptides. II. Comparison of recombination and biochemical maps. J Virol (1980) 1.04
Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinformatics (2005) 1.04
Screening of anti-bacterial activity of medicinal plants from Belize (Central America). J Ethnopharmacol (2003) 1.03
Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Mol Biol Cell (1998) 1.03
Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination. Epidemiol Infect (1987) 1.02
A sensitive method for the detection and isolation of recombinants of foot-and-mouth disease virus. J Gen Virol (1981) 1.02
A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J Virol (1998) 1.01
Interaction of classical swine fever virus with dendritic cells. J Gen Virol (2004) 1.01
Sequence determination of reduction potentials by cysteinyl hydrogen bonds and peptide pipoles in [4Fe-4S] ferredoxins. Biophys J (2001) 1.00
Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. J Virol (1985) 1.00
Modulation of monocytic cell activity and virus susceptibility during differentiation into macrophages. J Immunol (1999) 0.99
Immunological characterization of a low molecular mass polypeptidic antigen of Borrelia burgdorferi. FEMS Microbiol Immunol (1991) 0.99